DRI Healthcare Trust, managed by DRI Capital, is a pioneer and a leading global investor in the pharmaceutical royalty market. Established in 1992, the company's core business is acquiring royalties on approved and commercial-stage pharmaceutical products from inventors, academic institutions, and life sciences companies. This strategy provides non-dilutive capital to innovators while allowing DRI to build a diversified portfolio of long-term, cash-generating assets for its investors. The company is publicly traded on the Toronto Stock Exchange (TSX: DHT.UN).

Founded in

United States